|
|
|
Volumn 13, Issue 3, 1999, Pages 397-432
|
|
Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 3: Prevention of osteoporosis and CV effects of estrogens and antiestrogens
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALENDRONIC ACID;
ANTIESTROGEN;
BISPHOSPHONIC ACID DERIVATIVE;
CALCITONIN;
CALCIUM CARBONATE;
CITRATE CALCIUM;
CONJUGATED ESTROGEN;
ESTROGEN;
ETIDRONIC ACID;
FLUORIDE;
FLUORIDE SODIUM;
MEDROXYPROGESTERONE;
PLACEBO;
RALOXIFENE;
TAMOXIFEN;
VITAMIN D;
BONE DENSITY;
BONE MASS;
BONE MINERAL;
BREAST CANCER;
CALCIUM INTAKE;
CANCER ADJUVANT THERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CARDIOVASCULAR EFFECT;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFECT;
ESTROGEN DEFICIENCY;
FEMALE;
HUMAN;
INTRANASAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
OVARY INSUFFICIENCY;
PATHOLOGIC FRACTURE;
POSTMENOPAUSE OSTEOPOROSIS;
VITAMIN SUPPLEMENTATION;
BONE DENSITY;
BREAST NEOPLASMS;
CARDIOVASCULAR DISEASES;
DIPHOSPHONATES;
ESTROGEN ANTAGONISTS;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
OSTEOPOROSIS, POSTMENOPAUSAL;
|
|
EID: 0032915643
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (54)
|
